跳到正文
原文
Nature 健康护理主题·· 5 天前AI 评分58

中国老年人高血压患病率达53.1%,知晓与治疗率分别为74.1%和54.5%

Prevalence, awareness, treatment, and control of hypertension among older adults in China

AI 导读

基于CHARLS 2015年数据的横断面研究显示,中国60岁及以上老年人高血压患病率为53.1%(约1.4亿成人),其中74.1%知晓自身病情、54.5%接受降压治疗,仅33.7%血压得到控制。

正文

Abstract

China contributes to approximately 20% of the global burden of hypertension; however, a nationwide epidemiological survey on the prevalence of hypertension among older adults is lacking. This study aimed to assess the prevalence, awareness, treatment, and control of hypertension among older adults in China. The data were derived from the China Health and Retirement Longitudinal Study (CHARLS) in 2015. We included 7,733 participants aged 60 years and older. The prevalence of hypertension was 53.1% (95% CI 51.7–54.6%), which is equivalent to 140 million adults aged 60 years or older with hypertension in China. Among the participants with hypertension, 74.1% (95% CI 72.5–75.8%) were aware of their condition, 54.5% (95% CI 52.5–56.5%) were treated, and only 33.7% (95% CI 31.8–35.6%) were controlled. Systolic blood pressure increased with age (r = 0.504, P < 0.001), whereas diastolic blood pressure decreased with age (r = − 0.175, P < 0.001). The prevalence of hypertension increased with age (P for trend < 0.001). The prevalence of hypertension was observed to be higher in urban areas (57.0%, 95% CI 53.7–60.3%) than in rural areas (51.2%, 95% CI 49.8–52.6%) (P = 0.002), along with the prevalence being higher in northern areas (56.8%, 95% CI 54.7–58.8%) than in southern areas (50.7%, 95% CI 48.8–52.7%) (P < 0.001). Spanning from the western provinces to the central provinces to the eastern areas, the prevalence of hypertension was 50.8% (95% CI 48.6–53.1%), 52.6% (95% CI 50.4–54.8%), and 55.6% (95% CI 52.7–58.5%) (P for trend < 0.001), respectively. Multivariable analysis revealed that older age (65–69 years group: OR = 1.292, 95% CI 1.105–1.512; 70–74 years group: OR = 1.482, 95% CI 1.235–1.779; 75–79 years group: OR = 1.922, 95% CI 1.569–2.355; ≥ 80 years group: OR = 2.192, 95% CI 1.739–2.764), living in northern areas (OR = 1.197, 95% CI 1.054–1.360), drinking more than once a month (OR = 1.187, 95% CI 1.000–1.410), obesity (OR = 2.568, 95% CI 1.977–3.336), diabetes (OR = 1.694, 95% CI 1.443–1.989), and dyslipidaemia (OR = 1.378, 95% CI 1.218–1.559) were positively correlated with hypertension, whereas being married (or cohabitating) (OR = 0.772, 95% CI 0.668–0.892) was negatively correlated with hypertension. The prevalence of hypertension was high in people aged 60 years or older in China; however, the rates of control of hypertension remain low. Efforts are needed to prevent hypertension and improve the treatment and control of hypertension.

Abbreviations

BMI:

Body mass index

CHARLS:

China Health and Retirement Longitudinal Study

CI:

Confidence interval

DBP:

Diastolic blood pressure

HDL-C:

High-density lipoprotein cholesterol

LDL-C:

Low-density lipoprotein cholesterol

OR:

Odds ratio

SBP:

Systolic blood pressure

SD:

Standard deviation

TC:

Total cholesterol

TG:

Triglyceride

Funding

We sincerely thank all the CHARLS staff and participants for their contributions. This study was supported by the Natural Science foundation of China (91746205).

Author information

Author notes

  1. Yang Zhang, Weiwei Tang and Huaan Du contributed equally to this work.

Authors and Affiliations

  1. Department of Traditional Chinese Medicine, Department of Integrated Traditional Chinese Medicine and Western Medicine, Sichuan University affiliated Chengdu Second People’s Hospital, Chengdu Second People’s Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China

    Yang Zhang & Quan Luo

  2. Department of Cardiology, Sichuan University affiliated Chengdu Second People’s Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China

    Yang Zhang, Chuan Huang & Xiaobo Huang

  3. School of Health Policy and Management, Nanjing Medical University, Nanjing, Jiangsu, China

    Weiwei Tang

  4. Department of Cardiology, University-Town Hospital of Chongqing Medical University, Chongqing, China

    Huaan Du

  5. Stroke Center, Sichuan University affiliated Chengdu Second People’s Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China

    Ronghua Xu

  6. Jiangxi Provincial Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Wenqiang Zhang

  7. Department of Medical Genetics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Wenqiang Zhang

Authors

  1. Yang Zhang
  2. Weiwei Tang
  3. Huaan Du
  4. Ronghua Xu
  5. Chuan Huang
  6. Wenqiang Zhang
  7. Quan Luo
  8. Xiaobo Huang

Corresponding authors

Correspondence to Wenqiang Zhang, Quan Luo or Xiaobo Huang.

Ethics declarations

Ethics approval and consent to participate

The study protocol has been approved by Peking University’s Ethics Review Committee (Institutional Review Committee) (IRB 00001052–11014). All participants provided informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Tang, W., Du, H. et al. Prevalence, awareness, treatment, and control of hypertension among older adults in China. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78911-6

Download citation

  • Received: 03 December 2024

  • Accepted: 28 October 2026

  • Published: 15 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-78911-6

Keywords

来源:Nature 健康护理主题 · nature.com